Mergers & Acquisitions
Mar. 4, 2003
Johnson & Johnson Will Buy Biotech Firm
Johnson & Johnson has agreed to buy Sunnyvale's Scios Inc. for $2.4 billion in cash to enhance its biotechnology arsenal. Silicon Valley partner Christopher Kaufman of Latham & Watkins is advising Scios, a 22-year-old biotech company traded on Nasdaq.




Silicon Valley partner Christopher Kaufman of Latham & Watkins is advising Scios, a 22-year-old biotech company traded on Nasdaq.
&nb...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In